Autoantigen-specific memory CD4 + T cells are prevalent early in progression to Type 1 diabetes

Cellular Immunology

Volumn 273, Issue 2, 2012, Pages 133-139

  Öling, Viveka ^a   Reijonen, Helena ^b   Simell, Olli ^a   Knip, Mikael ^c,d   Ilonen, Jorma ^a,e  

^a UNIVERSITY OF TURKU   (Finland)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

GAD65; Insulin; T cells; T1D

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; HLA DR ANTIGEN; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TETRAMER;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CHILD; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; GLUTAMATE DECARBOXYLASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; INSULIN; INSULIN-SECRETING CELLS; LYMPHOCYTE ACTIVATION; POLYMERIZATION;

EID: 84857195656     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.12.008     Document Type: Article

References (37)

1. Westerberg L.S., Klein C., Snapper S.B. Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency-lessons learned from monogenic disorders in mice and men. Curr. Opin. Immunol. 2008, 20:646-654.
2. Eisenbarth G.S. Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 1986, 314:1360-1368.
3. Knip M., Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun. Rev. 2008, 7:550-557.
4. Pinkse G.G., Tysma O.H., Bergen C.A., Kester M.G., Ossendorp F., van Veelen P.A., et al. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc. Natl. Acad. Sci. USA 2005, 102:18425-18430.
5. Roep B.O. The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia 2003, 46:305-321.
6. Di Lorenzo T.P., Peakman M., Roep B.O. Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin. Exp. Immunol. 2007, 148:1-16.
7. Panagiotopoulos C., Trudeau J.D., Tan R. T-cell epitopes in type 1 diabetes. Curr. Diab. Rep. 2004, 4:87-94.
8. Bingley P.J., Christie M.R., Bonifacio E., Bonfanti R., Shattock M., Fonte M.T., et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994, 43:1304-1310.
9. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Chase H.P., et al. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J. Autoimmun. 1996, 9:379-383.
10. Kimpimäki T., Kupila A., Hämäläinen A.M., Kukko M., Kulmala P., Savola K., et al. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J. Clin. Endocrinol. Metab. 2001, 86:4782-4788.
11. Achenbach P., Bonifacio E., Koczwara K., Ziegler A.G. Natural history of type 1 diabetes. Diabetes 2005, 54(Suppl. 2):S25-S31.
12. Karlsen A.E., Hagopian W.A., Grubin C.E., Dube S., Disteche C.M., Adler D.A., et al. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc. Natl. Acad. Sci. USA 1991, 88:8337-8341.
13. Lieberman S.M., DiLorenzo T.P. A comprehensive guide to antibody and T-cell responses in type 1 diabetes. Tissue Antigens 2003, 62:359-377.
14. Endl J., Otto H., Jung G., Dreisbusch B., Donie F., Stahl P., et al. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 1997, 99:2405-2415.
15. Wicker L.S., Chen S.L., Nepom G.T., Elliott J.F., Freed D.C., Bansal A., et al. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. J. Clin. Invest. 1996, 98:2597-2603.
16. 4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J. Autoimmun. 2005, 25:235-243.
17. 4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 2004, 53:1987-1994.
18. Reijonen H., Novak E.J., Kochik S., Heninger A., Liu A.W., Kwok W.W. Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 2002, 51:1375-1382.
19. Standifer N.E., Burwell E.A., Gersuk V.H., Greenbaum C.J., Nepom G.T. Changes in autoreactive T cell avidity during type 1 diabetes development. Clin. Immunol. 2009, 132:312-320.
20. Marttila J., Huttunen S., Vaarala O., Suzuki K., Elliott J.F., Närvänen A., et al. T-cell reactivity to insulin peptide A1-12 in children with recently diagnosed type 1 diabetes or multiple beta-cell autoantibodies. J. Autoimmun. 2008, 31:142-148.
21. Mannering S.I., Harrison L.C., Williamson N.A., Morris J.S., Thearle D.J., Jensen K.P., et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J. Exp. Med. 2005, 202:1191-1197.
22. 4+ T cell epitopes in human type 1 diabetes. Clin. Exp. Immunol. 2009, 156:226-231.
23. Kent S.C., Chen Y., Bregoli L., Clemmings S.M., Kenyon N.S., Ricordi C., et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005, 435:224-228.
24. Durinovic-Bello I., Boehm B.O., Ziegler A.G. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity. J. Autoimmun. 2002, 18:55-66.
25. Viglietta V., Kent S.C., Orban T., Hafler D.A. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J. Clin. Invest. 2002, 109:895-903.
26. Danke N.A., Koelle D.M., Yee C., Beheray S., Kwok W.W. Autoreactive T cells in healthy individuals. J. Immunol. 2004, 172:5967-5972.
27. 4+ T cells in healthy and type 1 diabetic subjects. J. Autoimmun. 2005, 25:303-311.
28. Endl J., Rosinger S., Schwarz B., Friedrich S.O., Rothe G., Karges W., et al. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes. Diabetes 2006, 55:50-60.
29. Monti P., Scirpoli M., Rigamonti A., Mayr A., Jaeger A., Bonfanti R., et al. Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes. J. Immunol. 2007, 179:5785-5792.
30. Arif S., Tree T.I., Astill T.P., Tremble J.M., Bishop A.J., Dayan C.M., et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 2004, 113:451-463.
31. Kupila A., Muona P., Simell T., Arvilommi P., Savolainen H., Hämäläinen A.M., et al. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 2001, 44:290-297.
32. Hermann R., Turpeinen H., Laine A.P., Veijola R., Knip M., Simell O., et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003, 62:162-169.
33. Kukko M., Kimpimäki T., Korhonen S., Kupila A., Simell S., Veijola R., et al. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J. Clin. Endocrinol. Metab. 2005, 90:2712-2717.
34. Näntö-Salonen K., Kupila A., Simell S., Siljander H., Salonsaari T., Hekkala A., et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 2008, 372:1746-1755.
35. Masewicz S.A., Papadopoulos G.K., Swanson E., Moriarity L., Moustakas A.K., Nepom G.T. Modulation of T cell response to hGAD65 peptide epitopes. Tissue Antigens 2002, 59:101-112.
36. Herold K.C., Brooks-Worrell B., Palmer J., Dosch H.M., Peakman M., Gottlieb P. Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. Diabetes 2009, 58:2588-2595.
37. Trudeau J.D., Kelly-Smith C., Verchere C.B., Elliott J.F., Dutz J.P., Finegood D.T., et al. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 2003, 111:217-223.